Thank you for your interest in this survey.
TrialScreen is working with Scleroderma Australia to connect more people to health research and provide more options to everyone's healthcare journey. We are looking to host free-to-attend webinars and more resources about health research studies for people living with Scleroderma in 2024. To make sure the content is relevant and of value, we invite you to complete this survey about Scleroderma research areas that you are interested in.
This survey will take about 4 minutes to complete.
If you have any questions, please email Nick Lam, patient outreach lead, via
research@trialscreen.org.
PRIVACY NOTICE: Your privacy is of utmost importance. This survey platform, Alchemer, is compliant with The Health Insurance Portability and Accountability Act of 1996 (HIPAA). TrialScreen is compliant with the Australia Privacy Act 1988, HIPPA, and the General Data Protection Regulation (EU) 2016/679 (GDPR). All responses will be de-identified for analysis. The de-identified response will be stored in our secure database for up to 5 years, allowing for longitudinal analysis, and be deleted afterwards.
Aggregated results from the analysis using deidentified data will be shared with Scleroderma Australia, researchers and our partners, and on TrialScreen's website (trialscreen.org) and social media channels.
This question requires a valid number format.